Neurocrine Biosciences' GAAP net income for the six months of 2021 was $74.4 million, down 36.4% from $117 million in the previous year. Revenue decreased 2.6% to $525.5 million from $539.5 million a year earlier.
Neurocrine Biosciences' GAAP net income for the six months of 2021 was $74.4 million, down 36.4% from $117 million in the previous year. Revenue decreased 2.6% to $525.5 million from $539.5 million a year earlier. 
neurocrine.gcs-web.com
English (US) 